|
GYS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.411200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.654400E-01 |
| Normal-vs-Stage2 |
6.752400E-01 |
| Normal-vs-Stage3 |
1.159360E-01 |
| Normal-vs-Stage4 |
6.317800E-01 |
| Stage1-vs-Stage2 |
6.914400E-01 |
| Stage1-vs-Stage3 |
7.526500E-02 |
| Stage1-vs-Stage4 |
5.619800E-01 |
| Stage2-vs-Stage3 |
4.213600E-01 |
| Stage2-vs-Stage4 |
8.450000E-01 |
| Stage3-vs-Stage4 |
6.714600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.636800E-01 |
| Normal-vs-AfricanAmerican |
4.436800E-01 |
| Normal-vs-Asian |
2.372800E-01 |
| Caucasian-vs-AfricanAmerican |
4.799200E-01 |
| Caucasian-vs-Asian |
7.466300E-02 |
| AfricanAmerican-vs-Asian |
1.181380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.559400E-01 |
| Normal-vs-Female |
1.901780E-03 |
| Male-vs-Female |
1.611980E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.242800E-01 |
| Normal-vs-Extreme_Weight |
2.646200E-01 |
| Normal-vs-Obese |
1.943240E-01 |
| Normal-vs-Extreme_Obese |
7.269400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.629230E-01 |
| Normal_Weight-vs-Obese |
7.543000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.560400E-01 |
| Extreme_Weight-vs-Obese |
3.758000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.635400E-01 |
| Obese-vs-Extreme_Obese |
9.004200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.611600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.939000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.227000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.186800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.370000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.087600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.679010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.209800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.396570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.810600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.125800E-01 |
| Normal-VS-Type2 PRCC |
9.630200E-01 |
| Normal-VS-KIRP CIMP |
1.428760E-01 |
| Normal-VS-Unclassified PRCC |
3.022400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.879600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.462480E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.778200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.184200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.296400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.116400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.166400E-01 |
| Normal-vs-N1 |
3.620200E-01 |
| Normal-vs-N2 |
1.403000E-01 |
| N0-vs-N1 |
6.798400E-01 |
| N0-vs-N2 |
4.149900E-02 |
| N1-vs-N2 |
9.343900E-02 |
|
|
